Delivery Order SPE2DB22D2007-SPE2DB23FJ4LW
Award Date 7/26/23
Potential Completion Date 7/27/23
Potential Value $104
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $103,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 gram of gemcitabine in 26.3 milliliter vials. The single delivery order is to be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 26, 2023 to fulfill the Defense Logistics Agency's requirements for this chemotherapy drug. No additional details were provided regarding the context or purpose of the procurement, subcontractors, or designation...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $183,400 firm fixed price delivery order by the Defense Logistics Agency to provide 1 gram vials of gemcitabine hydrochloride. The single day contract issued on September 12, 2023 will be performed in Conshohocken, Pennsylvania and has a period of performance concluding on September 13, 2023. No additional details were provided regarding the original solicitation or whether this delivery order...
- The Defense Logistics Agency awarded a $207 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 gram of gemcitabine. The product will be delivered from Amerisourcebergen's Conshohocken, Pennsylvania facility to an unknown customer by September 29, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor. This delivery order was issued under an existing DLA contract vehicle, though details of the contract...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at thirty-nine thousand three hundred twenty dollars and thirty-two cents ($39,320.32) by the Defense Logistics Agency Troop Support Medical (DLA) to provide four hundred fifty-six thousand two hundred seventy-two (456,272) units of Gemcitabine hydrochloride, one gram per ten milliliter vials. Place of performance will be Amerisourcebergen's facility...
- The Defense Logistics Agency Troop Support Medical awarded a $103,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 gram vials of gemcitabine. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania distribution facility by July 10, 2023. Amerisourcebergen Drug Corporation is a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution services provider to the agency. This delivery order was issued...
- The Defense Logistics Agency awarded a $257 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 grams of gemcitabine. The contract has a period of performance of one day, from July 31, 2023 through August 1, 2023. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for providing supplies and services to the military...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,012.60 firm fixed price delivery order by the Defense Logistics Agency to supply 2 grams of gemcitabine for intravenous injection. The delivery order is associated with DLA's prime vendor program and supports the Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from July 20th through the 21st of 2023. No...
- This delivery order for $207 against the Defense Logistics Agency's pharmaceutical supply contract awards Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 1 gram of gemcitabine for intravenous injection. The product will be delivered to a location in Conshohocken, Pennsylvania by October 12, 2023. No set-aside designation was applied to this firm fixed-price order, which supports the Defense Logistics Agency's mission to provide pharmaceuticals and...
- <p>The Defense Logistics Agency awarded a $202,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 grams of gemcitabine. The contract has a period of performance from July 28, 2023 through July 31, 2023. Amerisourcebergen will deliver the pharmaceutical to its facility located in Conshohocken, Pennsylvania in support of the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified.</p>
- This firm fixed price delivery order for $62 was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp for 1 gram of gemcitabine in a 26.3 ml vial. The place of performance is Conshohocken, Pennsylvania and the completion date is October 6, 2023. No set aside designation was used for this order, which was issued against an existing contract vehicle to supply pharmaceutical products in support of DLA Troop Support Medical programs. Amerisourcebergen will...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ4LWDelivery Order
The Defense Logistics Agency awarded a $103.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561608185 Gemcitabine 1 gram/26.3 ml vials. The delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the delivery of the chemotherapy drug without use of major subcontractors. The award supports DLA's mission to provide logistics support for all military services and coalition partners.
Generated 12/23/23, 3:07 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $104 | 7/26/23 |